Sort
16,300 grants matching “fatty liver disease”
Novel imprint control regions (ICRs) responsive to environmental exposures
$623,055Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2021 · ES
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$622,831Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DK
Microbial Disruption of Dendritic Cell Maturation and Function
$622,687Caroline A Genco · Tufts University Boston · R01 · FY2019 · AI
Genetic determinants of Bacteroides vulgatus colonization fitness and host inflammatory responses
$622,416John F Rawls · Duke University · R01 · FY2024 · DK
Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis
$622,049Karen R Jonscher · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
Metabolic regulation and inhibition of ATP-citrate lyase
$622,037Ronen Marmorstein · University Of Pennsylvania · R01 · FY2023 · CA
Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis
$621,994Karen R Jonscher · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · DK
Metabolomic predictors of insulin resistance and diabetes
$621,842Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Lymphatics in the liver
$621,696Yasuko Iwakiri · Yale University · R01 · FY2022 · DK
Study of Longitudinal Aging in Mice
$621,558Rafael De Cabo · National Institute On Aging · ZIA · FY2017 · AG
Development of P2Y Receptor Ligands
$621,513Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Defining intra-renal ketone metabolism in kidney health and disease
$621,312Sarah Huen · Ut Southwestern Medical Center · R01 · FY2024 · DK
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2
$621,301David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2017 · DK
Metabolomic predictors of insulin resistance and diabetes
$621,278Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
$621,189Mariana Gerschenson · University Of Hawaii At Manoa · R01 · FY2011 · AI
Cyanobacteria, cyanotoxins, and liver cancer development
$621,174Brenda Y Hernandez · University Of Hawaii At Manoa · U01 · FY2024 · CA
Community Engagement Core
$621,003Michele D Kipke · Children'S Hospital Of Los Angeles · P50 · FY2024 · MD
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
$620,997Todd R. Golub · Broad Institute, Inc. · R01 · FY2016 · CA
The altered lipid and protein metabolism of pediatric patients with HIV infection
$620,915Farook Jahoor · Baylor College Of Medicine · R01 · FY2008 · HD
Microbial Disruption of Dendritic Cell Maturation and Function
$620,801Caroline A Genco · Tufts University Boston · R01 · FY2020 · AI
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
$620,779Ursula White · Lsu Pennington Biomedical Research Ctr · R01 · FY2023 · DK
Hyperhomocysteinemia and HDL Metabolism
$620,768Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
Hyperhomocysteinemia and HDL Metabolism
$620,768Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2017 · HL
Multi-omics for obesity-associated liver disease in a high-risk population cohort
$620,675Joseph B. McCormick · University Of Texas Hlth Sci Ctr Houston · U01 · FY2025 · CA
Prevention of Pediatric NAFLD in Hispanic Children
$620,659Miriam B. Vos · Emory University · R01 · FY2021 · NR